How is gene-expression profiling going to challenge the future management of lung cancer?
about
Meta-analysis of microarray data using a pathway-based approach identifies a 37-gene expression signature for systemic lupus erythematosus in human peripheral blood mononuclear cells5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis.[Long-term survival of personalized surgical treatment of locally advanced non-small cell lung cancer based on molecular staging].
P2860
How is gene-expression profiling going to challenge the future management of lung cancer?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How is gene-expression profiling going to challenge the future management of lung cancer?
@en
How is gene-expression profiling going to challenge the future management of lung cancer?
@nl
type
label
How is gene-expression profiling going to challenge the future management of lung cancer?
@en
How is gene-expression profiling going to challenge the future management of lung cancer?
@nl
prefLabel
How is gene-expression profiling going to challenge the future management of lung cancer?
@en
How is gene-expression profiling going to challenge the future management of lung cancer?
@nl
P2093
P2860
P356
P1433
P1476
How is gene-expression profiling going to challenge the future management of lung cancer?
@en
P2093
Cesar A Perez
Edgardo S Santos
Luis E Raez
P2860
P304
P356
10.2217/FON.09.60
P407
P577
2009-08-01T00:00:00Z